danofloxacin has been researched along with mobic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, AI; Alvarez-Fernandez, I; Blanco-Paniagua, E; Garcia-Lino, AM; Garcia-Mateos, D; Medina, JM; Merino, G | 1 |
1 trial(s) available for danofloxacin and mobic
| Article | Year |
|---|---|
Role of eprinomectin as inhibitor of the ruminant ABCG2 transporter: Effects on plasma distribution of danofloxacin and meloxicam in sheep.
Topics: Animals; Anthelmintics; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line; Female; Fluoroquinolones; Ivermectin; Lactation; Meloxicam; Sheep | 2021 |